The overexpression of HOXC10 in breast cancer is related to drug resistance to chemotherapy (Sadik et al., 2016) and a positive correlation between immune cell infiltration and poor prognosis in BRCAs (Zhang et al., 2022). Here, HOXC10 is linked to breast cancer.